Amsterdam institute for Immunology and Infectious diseases

The use of ASDAS to evaluate disease activity and response to treatment in patients with axial spondyloarthritis starting the first biological drug: Are ASAS recommendations being followed?

Santos, M. E., Ramiro, S., van der Heijde, D. S., Landewé, R., Cruz-Machado, A. R., Ferreira, C. C., Marques-Gomes, C., Soares, C. D., Miguel, C., Albuquerque, F., Martins, F., Silva, L. G., Santos, H., Almeida, I., Bernardes, M., Khmelinskii, N., Valente, P., Teixeira, P. M., Matias, S. E. & Fraga, V. & 3 others, Pimentel-Santos, F., Branco, J. C. & Sepriano, A., 1 Oct 2025, In: Seminars in Arthritis and Rheumatism. 74, 152781.

Research output: Contribution to journal › Article › Academic › peer-review

EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia

van Steenbergen, H. W., Doornkamp, F., Alivernini, S., Backlund, J., Codreanu, C., Cohen, S. B., Combe, B., Cope, A. P., Deane, K. D., England, B. R., Falahee, M., de Jong, P. H. P., Kleyer, A., Lacaille, D., Maat, B., Mankia, K., van Mulligen, E., Nagy, G., O'Neil, L. J. & Rodamaker, L. & 12 others, Sahbudin, I., van Schaardenburg, D., Sepriano, A., da Silva, J. A. P., de Smet, L., Sparks, J. A., Steyerberg, E. W., Studenic, P., Wethington, E., Landewé, R. L., Raza, K. & van der Helm-van Mil, A. H. M., Sept 2025, In: Annals of the rheumatic diseases. 84, 9, p. 1445-1457 13 p.

Research output: Contribution to journal › Article › Academic › peer-review

Summary of Research: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies

Mease, P. J., Merola, J. F., Tanaka, Y., Gossec, L., McInnes, I. B., Ritchlin, C. T., Landewé, R. B. M., Asahina, A., Ink, B., Heinrichs, A., Bajracharya, R., Shende, V., Coarse, J. & Coates, L. C., Aug 2025, In: Rheumatology and therapy. 12, 4, p. 609-612 4 p.

Research output: Contribution to journal › Article › Academic › peer-review